Effect of 3 weeks' rehabilitation on neutrophil surface antigens and lung function in cystic fibrosis

European Respiratory Journal

Volumn 15, Issue 5, 2000, Pages 942-948

  Nikolaizik, W H ^a   Simon, H U ^b   Iseli, P ^c   Blaser, K ^b   Schoni M H ^d  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^c Alpine Children's Hospital Davos   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bronchoalveolar lavage; Cystic fibrosis; Inflammation; Lung function; Neutrophils; Rehabilitation

Indexed keywords

CD11B ANTIGEN; CD32 ANTIGEN; CELL SURFACE MARKER; COMPLEMENT COMPONENT C3B RECEPTOR; MEMBRANE ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; LUNG FUNCTION; LUNG INFILTRATE; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD; ANTIGENS, SURFACE; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG; MALE; NEUTROPHILS; TIME FACTORS;

EID: 0034027956     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15e22.x     Document Type: Article

References (31)

1. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448-454.
2. Bretz U, Baggiolini M. Biochemical and morphological characterization of azurophil and specific granules of human neutrophil polymorphonuclear leukocytes. J Cell Biol 1974; 63: 251-269.
3. Campanelli D, Detmers PA, Nathan CF, Gabay JE. Azurocidin and a homologous serine protease from neutrophils, differential microbial and proteolytic properties. J Clin Invest 1990; 85: 904-915.
4. Suter S, Schaad UB, Tegner H, Ohlsson K, Desgrandchamps D, Waldvogel FA. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis 1986; 153: 902-909.
5. Dunn MM, Dunne M, Kamp DW. Polymorphonuclear leukocyte- and Pseudomonas aeruginosa-mduced damage to a human pulmonary epithelial line. J Infect Dis 1990; 162: 172-177.
6. 1-antitrypsin to suppress the burden of active neutrophil elastase on the respiratory epithelial surface in cystic fibrosis. Lancet 1991; 337: 392-394.
7. Kuijpers TW, Tool ATJ, van der School CE, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 78: 1105-1111.
8. Frederiksen B, Lanng S, Koch C, Høiby N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996; 21: 153-158.
9. Frederiksen B, Koch C, Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997; 23: 330-335.
10. McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term-comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997; 131: 570-574.
11. Miller S, Hall DO, Clayton CB, Nelson R. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax 1995; 50: 165-169.
12. Konstan MW, Stern RC, Doershuk CF. Efficacy of the flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994; 124: 689-693.
13. Pryor JA, Webber BA, Hodson ME, Warner JO. The Flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis. Respir Med 1994; 88: 677-681.
14. Van Winden CM, Visser A, Hop W, Sterk PJ, Beckers S, de Jongste JC. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. Eur Respir J 1988; 12: 143-147.
15. Nikolaizik WH, Knöpfli B, Leister E, de Boer P, Sievers B, Schöni MH. The anaerobic threshold in cystic fibrosis: comparison of V-slope method, lactate turn points, and Conconi test. Pediatr Pulmonol 1998; 25: 147-153.
16. Schöni MH, Nikolaizik WH. Aerosol therapy in patients with cystic fibrosis. Schweiz Med Wochenschr 1997; 127: 158-164.
17. Raschke B, Nikolaizik WH, Schöni MH. Successful rehabilitation in patients with cystic fibrosis. Monatsschr Kinderheilkd 1996; 144: 1051 (abstract).
18. Raschke B, Nikolaizik WH, Schöni MH. Effektivität einer Rehabilitation bei Patienten mit Cystischer Fibrose. Pneumologie 1997; 51: 240 (abstract).
19. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987; 136: 1285-1289.
20. American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991; 144: 1202-1208.
21. Polgar G, Promadhat V. Pulmonary Function Testing in Children. Techniques and Standards. Philadelphia, Saunders, 1971.
22. Morris JF. Spirometry in the evaluation of pulmonary function. Med J Med 1976; 125: 110-118.
23. Ratjen F, Bredendiek M, Brendel M, Meltzer J, Costabel U. Differential cytology of bronchoalveolar lavage fluid in normal children. Eur Respir J 1994; 7: 1865-1870.
24. Shwachman H, Kulczycki L. Long-term study of one hundred five patients with cystic fibrosis. Am J Dis Child 1958; 96: 6-15.
25. Berger M, O'Shea J, Cross AS, et al. Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest 1984; 74: 1566-1571.
26. Werfel T, Sonntag G, Weber MH, Götze O. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fc gamma-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J Immunol 1991; 147: 3909-3914.
27. Berger M, Sorensen RU, Tosi MF, Dearborn DG, Döring G. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989; 84: 1302-1313.
28. Ravetch JV, Kinet J-P. Fc receptors. Ann Rev Immunol 1991; 9: 457-492.
29. Birrer P, McElvaney NG, Rüdeberg A, et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 1994; 150: 207-213.
30. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-1082.
31. Fischer GF, Majdic O, Gadd S, Knapp W. Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol 1990; 144: 638-641.